Common heart pill may fight deadly liver scarring
NCT ID NCT04550481
Summary
This study is testing if lisinopril, a medication commonly used for high blood pressure, can help slow or prevent the progression of advanced fatty liver disease (NAFLD). It involves about 45 adults who already have significant liver scarring. Participants take the drug daily for 24 weeks while researchers measure changes in blood markers and scans related to liver health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NONALCOHOLIC STEATOHEPATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cedars Sinai Medical Center
Los Angeles, California, 90048, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
-
Mount Sinai Hospital
New York, New York, 10029, United States
Conditions
Explore the condition pages connected to this study.